Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
160 pending office actions • 85 clients • 139 examiners • 84 art units • 0 of 160 (0%) have an AI response strategy ready • 138 patents granted in the last 365 days
Ipsilon USA - NLO operates in Biotechnology & Pharmaceuticals and has 2,670 career applications recorded. Its resolved allowance rate is 81.42%, indicating allowance in a substantial portion of resolved matters but not across the full resolved record.
The profile lists 160 pending office actions, which represents a significant active examination workload. The average of 3.33 office actions per allowance shows that matters reaching allowance generally required multiple responses. For practitioners, the data highlights both the scale of current prosecution activity and the response effort associated with obtaining allowance.
Based on the USPTO statutory response window for each pending office action. 68 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 68 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 2 (1%) |
| §101 + other | 9 (6%) |
| §103 only | 48 (30%) |
| §102 only | 2 (1%) |
| §112 only | 6 (4%) |
| Double-patenting only | 2 (1%) |
| Double-patenting + other | 17 (11%) |
| Multi-statute (no §101) | 73 (46%) |
| No statute on record | 1 (1%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PAUL, SHREYA | 3 | 100.0% | +0.0% |
| LACHICA, ERICSON M | 3 | 29.8% | +35.2% |
| LANGEL, WAYNE A | 3 | 78.4% | +23.3% |
| GWARTNEY, ELIZABETH A | 3 | 36.0% | +34.9% |
| SKOKO III, JOHN JOSEPH | 3 | 53.0% | +55.2% |
| BOECKELMAN, JACOB A | 2 | 34.9% | +46.5% |
| YOO, HONG THI | 2 | 46.0% | +25.3% |
| HIBSHMAN, SARAH GRACE | 2 | 38.2% | +40.7% |
| LIU, DEBORAH YANG-HAO | 2 | 8.9% | +12.3% |
| CREWS, JARET JAMES | 2 | 43.9% | +71.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18866578 | A HARD SURFACE CLEANING COMPOSITION | PAUL, SHREYA | — |
| 18866584 | A HARD SURFACE CLEANING COMPOSITION | PAUL, SHREYA | — |
| 18866576 | A HARD SURFACE CLEANING COMPOSITION | PAUL, SHREYA | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17797450 | THERAPEUTIC COMBINATION FOR THE TREATMENT OF BRAIN ISCHEMIA AND SAID THERAPEUTIC COMBINATION FOR USE IN THE TREATMENT OF BRAIN ISCHEMIA | PEEBLES, KATHERINE | 189d overdue |
| 17785412 | CONFECTIONERY PRODUCT WITH REDUCED AMOUNT OF SUGAR AND MANUFACTURING PROCESS THEREOF | LACHICA, ERICSON M | 60d overdue |
| 17760508 | Method for the conversion of insects into nutrient streams and products resulting therefrom | LACHICA, ERICSON M | 60d overdue |
| 18043595 | OMPA MUTATIONS ENHANCE OMV PRODUCTION IN BORDETELLA PERTUSSIS | OGUNBIYI, OLUWATOSIN A | 53d overdue |
| 18042779 | OPHTHALMIC DYE | VU, JAKE MINH | 53d overdue |
| 19015573 | SLOW REACTING ACIDIZING COMPOSITIONS AND METHODS | RUNYAN, SILVANA C | 49d overdue |
| 18311910 | Method for providing dynamically customized messages in a healthcare facility | BALAJ, ANTHONY MICHAEL | 49d overdue |
| 17917265 | REMOVING WATER-SOLUBLE HEAVY METAL-SULFUR COMPLEX FROM PROCESS SOLUTION | KEYWORTH, PETER | 43d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17785412 | CONFECTIONERY PRODUCT WITH REDUCED AMOUNT OF SUGAR AND MANUFACTURING PROCESS THEREOF | LACHICA, ERICSON M | 60d overdue |
| 17760508 | Method for the conversion of insects into nutrient streams and products resulting therefrom | LACHICA, ERICSON M | 60d overdue |
| 17270928 | Thickened composition for dysphagia patients | GWARTNEY, ELIZABETH A | 30d overdue |
| 17629796 | Saponin derivatives with improved therapeutic window | CREWS, JARET JAMES | 7d |
| 18256057 | FIBRE MIXTURE FOR YOUNG CHILDREN | CREWS, JARET JAMES | 16d |
| 18012741 | COMBINATION COMPRISING AN ADC OR AN AOC COMPRISING A VHH, AND A SAPONIN OR A LIGAND-SAPONIN CONJUGATE | SKOKO III, JOHN JOSEPH | 26d |
| 18264085 | TWO-STAGE COOLING PROCESS FOR LARVAE PUREE | LIU, DEBORAH YANG-HAO | 56d |
| 18012723 | CONJUGATE OF A SINGLE DOMAIN ANTIBODY, A SAPONIN AND AN EFFECTOR MOLECULE, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, THERAPEUTIC USE OF SAID PHARMACEUTICAL COMPOSITION | SKOKO III, JOHN JOSEPH | 69d |
| Art Unit | Apps |
|---|---|
| 1792 | 7 |
| 1761 | 6 |
| 1791 | 6 |
| 1693 | 5 |
| 1637 | 5 |
| 1759 | 4 |
| 1657 | 4 |
| 1793 | 4 |
| 1736 | 4 |
| 1731 | 4 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19480379 | A SYSTEM AND METHOD FOR SEPARATING A STACK OF CARTON PAPERS | Mpac Langen B.V. | SEVERSON, JEREMY R | 1759 | §112 | Non-Final OA | — | Pending | Oct 31, 2025 |
| 19135838 | REGENERATION BY PROTOPLAST CALLUS GRAFTING | Keygene N.V. | SHEN, YANXIN NMN | 1663 | §112 | Non-Final OA | — | Pending | Jun 05, 2025 |
| 19226320 | PROCESSING AND DISTRIBUTING A DISTRIBUTION SCHEME | Roederer Management B.V. | GUNDRY, STEPHEN T | 2431 | §101§103§112 | Non-Final OA | — | Pending | Jun 03, 2025 |
| 19171508 | Card Based Lid with Scoop Holder and Scoop | N.V. Nutricia | ORTIZ, RAFAEL ALFREDO | 3736 | §103§112 | Non-Final OA | — | Pending | Apr 07, 2025 |
| 19084817 | Meal plan generating method, apparatus, and computer implemented algorithm thereof | Nutricia Early Life Nutrition (Shanghai) Co., Ltd. | COBANOGLU, DILEK B | 3687 | §101§103 | Final Rejection | 41d | Pending | Mar 20, 2025 |
| 19107064 | SILICIC ACID FOR IMPROVING MILK PRODUCTION IN DAIRY LIVESTOCK | Barlaa B.V. | LI, WENHAN | 1614 | §103§112Other | Non-Final OA | — | Pending | Feb 27, 2025 |
| 19106659 | HYDROGEL-CARRIERS FOR INDUCTION OF PLANT MORPHOGENESIS | Keygene N.V. | WILLIAMS, KEITH RICHARD | 1663 | §103§112 | Non-Final OA | — | Pending | Feb 26, 2025 |
| 19104240 | Beta-hexosaminidase vectors | UNIVERSITA AUTÒNOMA DE BARCELONA | LOUNTOS, GEORGE THEMISTOCLIS | 1652 | §102§103§112 | Non-Final OA | — | Pending | Feb 17, 2025 |
| 19101629 | FLOATING STRUCTURE | Single Buoy Moorings Inc. | OLSON, LARS A | 3615 | §103 | Non-Final OA | — | Pending | Feb 06, 2025 |
| 19038723 | SYNERGISTIC COMPOSITIONS FOR IMPROVING MINERAL BIOACCESSIBILITY | Nutricia Early Life Nutrition (Shanghai) Co., Ltd. | PACKARD, BENJAMIN J | 1612 | §103§112DP | Non-Final OA | — | Pending | Jan 28, 2025 |
| 19015573 | SLOW REACTING ACIDIZING COMPOSITIONS AND METHODS | Energy Solutions (Us) LLC | RUNYAN, SILVANA C | 1616 | §102§103 | Non-Final OA | 49d overdue | Pending | Jan 09, 2025 |
| 18985099 | FFF PRINTING SYSTEM WITH A FILAMENT PATH LENGTH MEASURING DEVICE FOR ALIGNMENT OF FEEDER AND PREFEEDER | Ultimaker B.V. | CHIDIAC, NICHOLAS J | 1744 | §103DP | Non-Final OA | — | Pending | Dec 18, 2024 |
| 18876199 | Method, system, automated dispensing device and computer program product for determining compliance of medicament packages | VMI Holland B.V. | KOTIS, JOSHUA G | 3731 | §101§102§103 | Final Rejection | — | Pending | Dec 18, 2024 |
| 18874590 | Injector device | Crea Ip B.V. | ZIMBOUSKI, ARIANA | 3781 | §102§103§112DP | Non-Final OA | — | Pending | Dec 13, 2024 |
| 18874123 | FLOATING FOUNDATION FOR AN OFFSHORE WIND TURBINE AND METHOD OF CONSTRUCTION | Maridea B.V. | HAYES, JOVON E | 3615 | §102§103§112 | Non-Final OA | — | Pending | Dec 12, 2024 |
| 18961534 | Lidar based Road Condition Estimation for Passenger Vehicles | Volvo Car Corporation | SILVA, MICHAEL THOMAS | 3663 | §103 | Final Rejection | 1d overdue | Pending | Nov 27, 2024 |
| 18868856 | AEROBIC BIOLOGICAL WASTEWATER TREATMENT IN A CONTINUOUS FLOW REACTOR | Haskoningdhv Nederland B.V. | NGUYEN, BOI-LIEN THI | 1779 | §103§112 | Non-Final OA | — | Pending | Nov 25, 2024 |
| 18866578 | A HARD SURFACE CLEANING COMPOSITION | CONOPCO, INC. | PAUL, SHREYA | 1761 | §103Other | Final Rejection | — | Pending | Nov 18, 2024 |
| 18866584 | A HARD SURFACE CLEANING COMPOSITION | CONOPCO, INC. | PAUL, SHREYA | 1761 | §103 | Final Rejection | — | Pending | Nov 18, 2024 |
| 18866576 | A HARD SURFACE CLEANING COMPOSITION | CONOPCO, INC. | PAUL, SHREYA | 1761 | §103Other | Final Rejection | — | Pending | Nov 18, 2024 |
| 18942822 | Microbiota of infants born by caesarean section | Nutricia Early Life Nutrition (Shanghai) Co., Ltd. | EDWARDS, JESSICA FAYE | 1657 | §102§103§112DP | Non-Final OA | — | Pending | Nov 11, 2024 |
| 18859559 | CUP AND BLANK FOR FORMING | CONOPCO, INC. | DEMEREE, CHRISTOPHER R | 3734 | §102§112 | Non-Final OA | — | Pending | Oct 24, 2024 |
| 18858774 | Method, pharmacy, dispensing device, medication dispensing container and computer program product for dispensing discrete medicaments | VMI Holland B.V. | MARU, TEMESGEN MALLEDE | 3655 | §112 | Non-Final OA | — | Pending | Oct 22, 2024 |
| 18858762 | Bar-code printing device, method and computer program product for printing bar-codes | VMI Holland B.V. | HUNTSINGER, PETER K | 2682 | §102§103§112 | Non-Final OA | — | Pending | Oct 22, 2024 |
| 18857466 | IMPROVEMENTS TO INTRODUCER SHEATHS | Three Peaks Medical Pty Ltd. | MILLER, SERENITY A | 3771 | §103§112Other | Non-Final OA | — | Pending | Oct 17, 2024 |
| 18912628 | SHEET FOR USE IN PILL PACKAGES, AND POUCH FORMED FROM A SHEET | VMI Holland B.V. | ACKUN, JACOB K | 3736 | §102§103 | Final Rejection | 53d | Pending | Oct 11, 2024 |
| 18911290 | METHOD FOR ENHANCING EMBRYO IMPLANTATION | Nulife B.V. | PARK, HAEJIN S | 1614 | §103§112DP | Non-Final OA | — | Pending | Oct 10, 2024 |
| 18853157 | FLAVOUR DELIVERY SYSTEM | Flavour Products B.V. | LACHICA, ERICSON M | §103§112 | Non-Final OA | — | Pending | Oct 01, 2024 | |
| 18849557 | LARGE SCALE MANUFACTURING OF IPSC DERIVED HSC AND PROGENY | Celyntra Therapeutics SA | MIANO, JOSEPH PAUL | 1631 | §102§103§112 | Non-Final OA | — | Pending | Sep 23, 2024 |
| 18847267 | ILLUMINATOR END PART | Crea Ip B.V. | TRAN, HOANG Q | 2874 | §102§103 | Non-Final OA | — | Pending | Sep 16, 2024 |
| 18882789 | System and method for controlling a rotational moulding process | Ams Belgium Bvba | SAAVEDRA, EMILIO J | §103§112Other | Non-Final OA | — | Pending | Sep 12, 2024 | |
| 18882804 | Nutritional composition for cancer | N.V. Nutricia | BOECKELMAN, JACOB A | 1655 | §103 | Non-Final OA | — | Pending | Sep 12, 2024 |
| 18843752 | PROCESS FOR THE PRODUCTION OF A STRUCTURED PROTEIN PRODUCT | CONOPCO, INC. | MORNHINWEG, JEFFREY P | 1793 | §102§103 | Non-Final OA | — | Pending | Sep 04, 2024 |
| 18817331 | Fatty acids for boostering ketogenic diet | N.V. Nutricia | MUKHOPADHYAY, BHASKAR | 1792 | §103§112 | Non-Final OA | — | Pending | Aug 28, 2024 |
| 18815872 | Fatty acids for ketosis control | N.V. Nutricia | WILSON, JERICA KATLYNN | 1621 | §101§102§103§112 | Non-Final OA | — | Pending | Aug 27, 2024 |
| 18840549 | A CHIMERIC ENDOLYSIN POLYPEPTIDE | Micreos Human Health B.V. | LANKFORD JR, LEON B | 1657 | §102 | Non-Final OA | — | Pending | Aug 22, 2024 |
| 18836815 | COSMETIC PRODUCT CONTAINING STERILE PCL MICROSPHERES | Sinclair Pharmaceuticals Ltd. | MILLER, MAKENNA RYLEIGH | 1611 | §103 | Non-Final OA | — | Pending | Aug 08, 2024 |
| 18832542 | INSTALLATION FOR MICROBIOLOGICAL WASTE WATER TREATMENT | Paques I.P. B.V. | SHIPMAN, KYLE HARRISON | §102§103§112 | Non-Final OA | — | Pending | Jul 24, 2024 | |
| 18729547 | A LIQUID PHARMACEUTICAL FORMULATION OF CLONIDINE HYDROCHLORIDE | Novumgen Limited | PETRITSCH, AMANDA MICHELLE | 1612 | §102§103§112DP | Non-Final OA | — | Pending | Jul 17, 2024 |
| 18772309 | Ophthalmic dye composition | Vitreq B.V. | WESTERBERG, NISSA M | 1618 | §103 | Final Rejection | 35d overdue | Pending | Jul 15, 2024 |
| 18764454 | Degradation of fluor containing substances by bioconversion | UNIVERSITEIT UTRECHT HOLDING B.V. | NORRIS, CLAIRE A | 1779 | §102§112 | Non-Final OA | — | Pending | Jul 05, 2024 |
| 18757549 | Delivery systems for TNE | Keygene N.V. | PAGE, BRENT T | 1663 | DP | Final Rejection | 15d | Pending | Jun 28, 2024 |
| 18723470 | Microbial communities | UNIVERSITEIT GENT | ARIANI, KADE | 1651 | §103§112 | Non-Final OA | — | Pending | Jun 24, 2024 |
| 18741853 | Mix of specific Bifidobacterium species and specific non-digestible oligosaccharides | N.V. Nutricia | YOO, HONG THI | 1792 | §103§112 | Non-Final OA | — | Pending | Jun 13, 2024 |
| 18731379 | SYSTEM AND METHOD FOR ACTIVATING A SURGICAL INSTRUMENT, AND FOOT SWITCH ASSEMBLY FOR CONTROLLING A SURGICAL INSTRUMENT | Crea Ip B.V. | ROANE, AARON F | 3792 | §102§112 | Non-Final OA | 6d | Pending | Jun 03, 2024 |
| 18677277 | RIM OF A BICYCLE WHEEL AND RELATED BICYCLE WHEEL | Campagnolo S.r.l. | PALMER, ALEX ROBERT | 3615 | §112 | Final Rejection | — | Pending | May 29, 2024 |
| 18661774 | Surgical Instrument and Surgical System | Stichting Het Nederlands Kanker Instituut - Antoni Van Leeuwenhoek Ziekenhuis | OGLES, MATTHEW ERIC | 3791 | §103§112 | Final Rejection | — | Pending | May 13, 2024 |
| 18707187 | Beta2-adrenergic receptor antagonists for use in treating diabetes or obesity | Novelyeast BV | NOTTINGHAM, KYLE GREGORY | 1621 | §103§112 | Non-Final OA | — | Pending | May 03, 2024 |
| 18704937 | Removal of micropollutants from water and installation for use therein | Wageningen Universiteit | ROTONDI, CONNOR JON | 1778 | §103§112 | Non-Final OA | — | Pending | Apr 26, 2024 |
| 18704078 | New conductive additive in lithium and sodium batteries | Carbonx Ip 10 B.V. | MCKINNON, LASHAWNDA T | 1789 | §103 | Non-Final OA | — | Pending | Apr 24, 2024 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial81.4% of resolved applications prosecuted by Ipsilon Usa - Nlo were allowed, across 2,670 applications in USPTO records.
3.33 office actions per allowed application on average.
160 pending office actions as of October 2026, for 85 clients, before 139 examiners in 84 art units.
